Lisa Piercey Acquires 949 Shares of National HealthCare (NYSEAMERICAN:NHC) Stock

Key Points

  • Director Lisa Piercey bought 949 shares of National HealthCare stock on June 1 at an average price of $184.26, a transaction worth about $174,863.
  • National HealthCare shares were up 2.2% and recently traded around $183.35, with the company valued at about $2.86 billion. The stock has ranged from a 12-month low of $93.54 to a high of $205.06.
  • The company raised its quarterly dividend to $0.67 per share from $0.64, implying an annualized payout of $2.68 and a yield of about 1.5%.

National HealthCare Corporation (NYSEAMERICAN:NHC - Get Free Report) Director Lisa Piercey bought 949 shares of the firm's stock in a transaction that occurred on Monday, June 1st. The stock was purchased at an average price of $184.26 per share, for a total transaction of $174,862.74. Following the completion of the transaction, the director directly owned 949 shares of the company's stock, valued at $174,862.74. This represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website.

National HealthCare Trading Up 2.2%

NYSEAMERICAN:NHC opened at $183.35 on Wednesday. The company has a market capitalization of $2.86 billion, a P/E ratio of 23.30 and a beta of 0.64. National HealthCare Corporation has a 12 month low of $93.54 and a 12 month high of $205.06. The business's 50-day moving average is $175.21 and its 200 day moving average is $156.01.

National HealthCare (NYSEAMERICAN:NHC - Get Free Report) last posted its earnings results on Thursday, May 7th. The company reported $1.91 EPS for the quarter. The company had revenue of $381.82 million for the quarter. National HealthCare had a return on equity of 9.98% and a net margin of 8.10%.

National HealthCare Increases Dividend




The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be given a $0.67 dividend. This is an increase from National HealthCare's previous quarterly dividend of $0.64. This represents a $2.68 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date is Tuesday, June 30th. National HealthCare's dividend payout ratio (DPR) is presently 59.12%.

Institutional Investors Weigh In On National HealthCare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Caitong International Asset Management Co. Ltd purchased a new stake in National HealthCare during the third quarter valued at approximately $25,000. Quarry LP raised its position in National HealthCare by 171.9% during the third quarter. Quarry LP now owns 261 shares of the company's stock valued at $32,000 after purchasing an additional 165 shares during the period. Kestra Advisory Services LLC purchased a new stake in National HealthCare during the fourth quarter valued at approximately $42,000. Simplex Trading LLC raised its position in National HealthCare by 140.0% during the fourth quarter. Simplex Trading LLC now owns 348 shares of the company's stock valued at $48,000 after purchasing an additional 203 shares during the period. Finally, EverSource Wealth Advisors LLC raised its position in National HealthCare by 28.5% during the first quarter. EverSource Wealth Advisors LLC now owns 311 shares of the company's stock valued at $50,000 after purchasing an additional 69 shares during the period. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

NHC has been the topic of a number of research analyst reports. Royal Bank Of Canada upgraded National HealthCare to a "hold" rating in a research report on Monday, May 18th. The Goldman Sachs Group upgraded National HealthCare to a "strong-buy" rating in a research report on Monday, May 18th. BMO Capital Markets upgraded National HealthCare to a "hold" rating in a research report on Monday, May 18th. Finally, Robert W. Baird upgraded National HealthCare to a "strong-buy" rating in a research report on Monday, May 18th. Two equities research analysts have rated the stock with a Strong Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, National HealthCare currently has an average rating of "Buy".

View Our Latest Research Report on National HealthCare

About National HealthCare

(Get Free Report)

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at National HealthCare?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for National HealthCare and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles